Rehbar Tayyabkhan

See the following -

Medidata And TransCelerate BioPharma Inc. Announce Joint Initiative

Press Release | Medidata, TransCelerate BioPharma Inc. | May 20, 2014

Collaboration to Explore Key Components of Recommended Risk-Based Monitoring Methodology

Read More »

TransCelerate BioPharma Inc. Releases First Update On Risk-Based Monitoring Of Clinical Trials Initiative, Yields Key Lessons And Training Materials

Press Release | TransCelerate BioPharma Inc. | January 30, 2014

In its continued effort to modernize and streamline the way clinical trials are conducted and monitored, TransCelerate BioPharma Inc.  ("TransCelerate") is providing the first update to its position paper outlining a methodology for risk-based site monitoring ("Risk-Based Monitoring" or "RBM") released in June 2013. Read More »